MarketWatch: Cancer
Pages: 34
Publisher: Datamonitor
Date Published: May 2006
Format: PDF
Price: $200
Overview
Datamonitor’s Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventures, and regulatory decisions.
Table of Contents
In this month’s MarketWatch…
This month’s highlights
Page 2 – Key Announcements
Page 2 – Cancer News Round-up
Leukemia / Myeloma News
Page 4 – News Headlines
Page 4 – Research & Development Update
Page 6 – Regulatory Update
Colorectal Cancer News
Page 8 – News Headlines
Page 8 – Research & Development Update
Page 10 – Regulatory Update
Other Cancers News
Page 11 – Opinion
Page 14 – News Headlines
Page 14 – Breast Cancer Update
Page 16 – Prostate Cancer Update
Page 18 – Lung Cancer Update
Feature Analysis
Page 19 – TeGenero Mab causes shock side-effects in UK trial
Page 20 – Neoadjuvant therapy next major change in gastric cancer treatment
Company Spotlight
Page 23 – Roche AG
Index
Page 30 – Pharma companies
Page 30 – Biotech companies
Page 31 – Key drugs
